|Articles|October 2, 2013
- Pharmaceutical Technology-10-02-2013
- Volume 37
- Issue 10
Pharmaceutical Technology, October 2013 Issue (PDF)
Click the title above to open the Pharmaceutical Technology October 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 13 years ago
Q&A with Amie Gehris, Dow Water and Process Solutionsalmost 13 years ago
Unraveling the Mystery of Ireland's Pharm-Attractionsalmost 13 years ago
Report from: Middle East and North Africaalmost 13 years ago
Maintaining and Verifying the Cold Chainalmost 13 years ago
Ensuring Compliance with Drug Accountability Requirementsalmost 13 years ago
The Expense of Vision in Outsourcingalmost 13 years ago
LCMS-8050 Mass Spectrometer Increases Quality Analysisalmost 13 years ago
Tracking Quality in Drug Manufacturingalmost 13 years ago
USP Seeks Input on Standards for Plastic Packaging Systemsalmost 13 years ago
RheocalcT Software Tests Parameters and Data CollectionAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Peptide Compounding Vote Raises New Questions for Drug Developers
3
Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates
4
What Jideytro's Approval Means for Drug Developers
5
